| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |